Crescent Biopharma, Inc. (CBIO) Net margin 2016–2025
Crescent Biopharma, Inc. (CBIO) net profit margin by fiscal year — reported net income divided by reported revenue.
-1419.6%FY2025 · since FY2016: -171945.1% → -1419.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1419.6% | — |
| FY2023 | -368994.2% | -306742.5 pp |
| FY2022 | -62251.7% | -56782.8 pp |
| FY2021 | -5469.0% | -4966.9 pp |
| FY2020 | -502.1% | — |
| FY2016 | -171945.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice